Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients.
D
D
Hernández-Romero
F
F
Marín
V
V
Roldán
G Y H
GY
Lip
D000925:Anticoagulants / Q000009:adverse effects*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced* / Q000401:mortality*; D006801:Humans; D008297:Male; D014859:Warfarin / Q000009:adverse effects*; D014841:von Willebrand Factor / Q000378:metabolism*
D000925:Anticoagulants; D014841:von Willebrand Factor; D014859:Warfarin